MP Biomedicals SARS-CoV-2 recombinant antigens and antibodies
01 May, 2020 | Supplied by: MP Biomedicals Australasia P/LTo join the fight against the 2019 novel coronavirus (COVID-19), MP Biomedicals now offers three monoclonal antibodies from mouse and five recombinant antigens for SARS-CoV-2, expressed in E. coli and HEK293.
ProteoGenix antibody library to help fight COVID-19
30 April, 2020ProteoGenix has announced its Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2 — claimed to be a world first.
BBI Solutions coronavirus reagents
29 April, 2020 | Supplied by: Assay MatrixBBI Solutions is offering recombinant SARS-CoV spike 1 and spike 2 glycoproteins and nucleoprotein for the 2019 novel coronavirus (SARS-CoV-2, COVID-19) and spike 1 glycoprotein for the related SARS coronavirus.
3D-printed copper kills SARS-CoV-2 on contact surfaces
24 April, 2020 | Supplied by: SPEE3DAdditive manufacturer SPEE3D has developed a fast and effective way to 3D print antimicrobial copper that 'contact kills' SARS-CoV-2 onto metal surfaces.
Bio-Rad Laboratories anti-ipilimumab antibodies
22 April, 2020 | Supplied by: Bio-Rad Laboratories Pty LtdThe highly specific and high-affinity antibodies are suitable for bioanalytical and patient drug level monitoring assays for the immune checkpoint inhibitor: ipilimumab.
Getinge DPTE Transfer Trolley
17 April, 2020 | Supplied by: Getinge Australia Pty LtdGetinge has launched the DPTE Transfer Trolley — a smart, mobile transfer platform for moving materials into and out of a confined zone without breaking containment or sterility.
Air Science UV-Box decontamination chamber
14 April, 2020 | Supplied by: LAF Technologies Pty LtdAir Science's UV-Box is a high-efficiency chamber designed to safely decontaminate contents while providing a safe work environment for the operator.
Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control
06 April, 2020 | Supplied by: Thermo Fisher ScientificIn an effort to combat the recent coronavirus outbreak, Thermo Fisher Scientific designed and developed the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control as a synthetic RNA, non-infectious control to help labs validate and monitor COVID-19 molecular diagnostic tests.
ClorDiSys Solutions Torch UV-C System
01 April, 2020 | Supplied by: AMT Group AustralasiaUV Solutionz High Energy Germicidal UVC Germicidal Technology is used for many applications, including killing airborne and surface pathogens such as coronavirus (COVID-19), other viruses, bacteria and moulds that live, replicate and move through the building via a building forced-air HVAC system.
Partnership provides tools for cell-based meat research
11 February, 2020Reagent company Kerafast has announced an agreement with The Good Food Institute, an organisation committed to making cultivated and plant-based meat and seafood a reality.
The challenges of working in a lab
28 January, 2020 | Supplied by: Westlab SuppliesAccidents in the lab are often unavoidable, but if you exercise attention to detail and thoroughness, you contribute to the excellent reputation of your lab and your research integrity.
Larodan research-grade glycerides
23 January, 2020 | Supplied by: Sapphire BioscienceLarodan develops a comprehensive range of research-grade lipids for use as analytical standards by users all over the world. The company's products include all kinds of lipids, from simple fatty acids and methyl esters to complex oxylipins, glycerides and phospholipids.
DEWALT safety glasses and goggles
17 January, 2020 | Supplied by: Mayo Hardware AustraliaDEWALT safety glasses and goggles are designed to ensure safe, efficient and comfortable vision in the occupational situation.
Bovogen Biologicals Ultra Low IgG FBS
01 December, 2019 | Supplied by: Scientifix Pty LtdBovogen Biologicals' foetal bovine serum (NZ origin) is manufactured in a fully validated sterile filtration facility, following strict GMP process, and is fully traceable.
Antibody research brings malaria vaccine one step closer
28 November, 2019Researchers have narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against the most severe forms of malaria.
